|
|
||||||||
1From the Institute of Human Genetics, National Research Center for Environment and Health (GSF), Neuherberg, Germany; the 2Department of Medical Genetics at the University of Munich, Munich, Germany; the 4University Eye Hospital Tübingen, Tübingen, Germany; the 6Center for Laboratory Medicine, Cantonal Hospital Aarau, Aarau, Switzerland; the 7Department of Paediatric Ophthalmology, Strabismology, and Ophthalmogenetics, Regensburg, Germany; the 8Molecular Genetics Laboratory, University Eye Hospital Tübingen, Tübingen, Germany; the 9Institute of Human Genetics, Münster, Germany; the 10University Eye Clinic, Munich, Germany; and 11GSF-Clinical Cooperation Group Ophthalmogenetics, Neuherberg, Germany.
PURPOSE. A comprehensive screening was conducted for RP2 and retinitis pigmentosa GTPase regulator (RPGR) gene mutations including RPGR exon ORF15 in 58 index patients. The frequency of RPGR mutations was assessed in families with definite X-linked recessive disease (xlRP), and a strategy for analyzing the highly repetitive mutational hot spot in exon ORF15 is provided.
METHODS. Fifty-eight apparently unrelated index-patients were screened for mutations in all coding exons of the RP2 and the RPGR genes, including splice-sites, by single-strand conformation polymorphism (SSCP) analysis, except for RPGR exon ORF15. A strategy for directly sequencing the large repetitive stretch of exon ORF15 from a 1.6-kb PCR-product was developed. According to pedigree size and evidence for X linkage, families were subdivided into three categories.
RESULTS. Screening of 58 xlRP families revealed RP2 mutations in 8% and RPGR mutations in 71% of families with definite X-linked inheritance. Mutations clustered within a
500-bp stretch in exon ORF15. In-frame sequence alterations in exon ORF15 ranged from the deletion of 36 bp to the insertion of 75 bp.
CONCLUSIONS. Mutations in the RPGR gene are estimated to cause 15% to 20% of all cases of RP, higher than any other single RP locus. This report provides a detailed strategy to analyze the mutational hot spot in RPGR exon ORF15, which cannot be screened by standard procedures. The discrepancy of the proportion of families linked to the RP3 locus and those having RPGR mutations is resolved in a subset of families with definite X linkage.
This article has been cited by other articles:
![]() |
S. Walia, G. A. Fishman, A. Swaroop, K. E. H. Branham, M. Lindeman, M. Othman, and R. G. Weleber Discordant Phenotypes in Fraternal Twins Having an Identical Mutation in Exon ORF15 of the RPGR Gene Arch Ophthalmol, March 1, 2008; 126(3): 379 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Aleman, A. V. Cideciyan, A. Sumaroka, S. B. Schwartz, A. J. Roman, E. A. M. Windsor, J. D. Steinberg, K. Branham, M. Othman, A. Swaroop, et al. Inner Retinal Abnormalities in X-linked Retinitis Pigmentosa with RPGR Mutations Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4759 - 4765. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-B. Jin, F. Gu, X. Ma, and N. Nao-i Identification of a Novel RPGR Exon ORF15 Mutation in a Family With X-linked Retinitis Pigmentosa Arch Ophthalmol, October 1, 2007; 125(10): 1407 - 1412. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Prokisch, M. Hartig, R. Hellinger, T. Meitinger, and T. Rosenberg A Population-Based Epidemiological and Genetic Study of X-Linked Retinitis Pigmentosa Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4012 - 4018. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Garcia-Hoyos, B. Garcia-Sandoval, D. Cantalapiedra, R. Riveiro, I. Lorda-Sanchez, M. J. Trujillo-Tiebas, M. Rodriguez de Alba, J. M. Millan, M. Baiget, C. Ramos, et al. Mutational Screening of the RP2 and RPGR Genes in Spanish Families with X-Linked Retinitis Pigmentosa. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3777 - 3782. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Shu, Z. Zeng, M. S. Eckmiller, P. Gautier, D. Vlachantoni, F. D. C. Manson, B. Tulloch, C. Sharpe, D. C. Gorecki, and A. F. Wright Developmental and Tissue Expression of Xenopus laevis RPGR Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 348 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Ebenezer, M. Michaelides, S. A. Jenkins, I. Audo, A. R. Webster, M. E. Cheetham, A. Stockman, E. R. Maher, J. R. Ainsworth, J. R. Yates, et al. Identification of Novel RPGR ORF15 Mutations in X-linked Progressive Cone-Rod Dystrophy (XLCORD) Families Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 1891 - 1898. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Shu, A.M. Fry, B. Tulloch, F.D.C. Manson, J.W. Crabb, H. Khanna, A.J. Faragher, A. Lennon, S. He, P. Trojan, et al. RPGR ORF15 isoform co-localizes with RPGRIP1 at centrioles and basal bodies and interacts with nucleophosmin Hum. Mol. Genet., May 1, 2005; 14(9): 1183 - 1197. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-H. Hong, B. S. Pawlyk, M. Adamian, and T. Li Dominant, Gain-of-Function Mutant Produced by Truncation of RPGR Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 36 - 41. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |